formic acid-(4-chloro-butyl ester) | 35161-80-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: formic acid-(4-chloro-butyl ester)
• 英文别名: Ameisensaeure-(4-chlor-butylester)；Ameisensaeure-<4-chlor-butylester>；4-Chlor-1-butylformiat；4-Chlorbutyl-formiat；4-Chlorobutyl formate
• CAS: 35161-80-9
• 化学式: C₅H₉ClO₂
• mdl: MFCD19232294
• 分子量: 136.578
• InChiKey: VSNYLPHROLHHQB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  8
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  formic acid-(4-chloro-butyl ester) 、 sodium formate 在 四丁基硫酸氢铵 作用下， 以 氯苯 为溶剂， 生成 1,4-butanediol diformate
  参考文献：
  名称：

  水在固液相转移催化的取代反应中的关键作用

  摘要：

  痕量水对季铵盐催化的取代反应至关重要。在含水量为0.2％的甲酸盐中，氯化物与甲酸盐的交换速率最高，而脱水剂的加入会使最大速率降低50％。

  DOI：

  10.1039/c39840001652
• 作为产物：
  描述：

  甲酸 、 1,4-二氯丁烷 生成 formic acid-(4-chloro-butyl ester)
  参考文献：
  名称：

  Kinetics in antimony pentafluoride-sulfur dioxide solution. Rate of reaction of tetramethylenechloronium ions with aliphatic carboxylic acids

  摘要：

  DOI：

  10.1021/ja00769a039

文献信息

• HALOALKYLSULFONANILIDE DERIVATIVE
  申请人：Kai Masanori

  公开号：US20120029187A1

  公开（公告）日：2012-02-02

  Novel herbicides are provided. A haloalkylsulfonanilide derivative represented by the formula (1) or an agrochemically acceptable salt thereof: the formula (1): wherein Z is —C(R 9 )(R 10 )— or —N(R 11 )—, A is an oxygen atom, a sulfur atom or —N(R 12 )—, W is an oxygen atom or a sulfur atom, m is an integer of from 0 to 3, n is an integer of from 0 to 3, m+n is from 1 to 3, R 1 is halo C 1 -C 6 alkyl, R 2 is a hydrogen atom, C 1 -C 6 alkyl or the like, each of R 3 and R 4 is independently a hydrogen atom, C 1 -C 6 alkyl or the like, each of R 5 , R 6 , R 7 , R 8 , R 9 and R 10 is independently a hydrogen atom, a halogen, C 1 -C 6 alkyl or the like, each of R 11 and R 12 is a hydrogen atom, C 1 -C 6 alkyl, halo C 1 -C 6 alkyl or the like, and X is independently a hydrogen atom, a halogen, C 1 -C 6 alkyl, or the like.

  提供新型除草剂。 一种由式（1）表示的卤烷基磺酰苯胺衍生物或其农药可接受的盐： 式（1）： 其中Z为—C(R9)(R10)—或—N(R11)—，A为氧原子、硫原子或—N(R12)—，W为氧原子或硫原子，m为0至3的整数，n为0至3的整数，m+n为1至3，R1为卤代C1-C6烷基，R2为氢原子、C1-C6烷基或类似物，R3和R4中的每一个独立地为氢原子、C1-C6烷基或类似物，R5、R6、R7、R8、R9和R10中的每一个独立地为氢原子、卤素、C1-C6烷基或类似物，R11和R12中的每一个为氢原子、C1-C6烷基、卤代C1-C6烷基或类似物，X独立地为氢原子、卤素、C1-C6烷基或类似物。
• [EN] CARBOSTYRIL COMPOUND<br/>[FR] DÉRIVÉ DE CARBOSTYRILE
  申请人：OTSUKA PHARMA CO LTD

  公开号：WO2006035954A1

  公开（公告）日：2006-04-06

  The present invention provides a carbostyril compound represented by General Formula (1) or a salt thereof, wherein A is a direct bond, a lower alkylene group, or a lower alkylidene group; X is an oxygen atom or a sulfur atom; R4 and R5 each represent a hydrogen atom; the bond between the 3 and 4 positions of the carbostyril skeleton is a single bond or a double bond; R1 is a hydrogen atom, etc; R2 is a hydrogen atom, etc; and R3 is a hydrogen atom, etc. The carbostyril compound or salt thereof of the present invention induces the production of TFF, and thus is usable for the treatment and/or prevention of disorders such as alimentary tract diseases, oral diseases, upper respiratory tract diseases, respiratory tract diseases, eye diseases, cancers, and wounds.

  本发明提供了一种由通式（1）表示的羧基吲哚化合物或其盐，其中A是直链键、较低的烷基烯基或较低的烷基亚烯基；X是氧原子或硫原子；R4和R5分别表示氢原子；羧基吲哚骨架的3和4位置之间的键是单键或双键；R1是氢原子，等等；R2是氢原子，等等；R3是氢原子，等等。本发明的羧基吲哚化合物或其盐诱导TFF的产生，因此可用于治疗和/或预防消化道疾病、口腔疾病、上呼吸道疾病、呼吸道疾病、眼部疾病、癌症和伤口等疾病。
• (3-FLUORO-2-HYDROXY)PROPYL-FUNCTIONALIZED ARYL DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR THE DIAGNOSIS OR TREATMENT OF NEURODEGENERATIVE BRAIN DISEASES
  申请人：Chi Dae-Yoon

  公开号：US20120214994A1

  公开（公告）日：2012-08-23

  The present invention relates to (3-fluoro-2-hydroxy)propyl-functionalized aryl derivatives or to the pharmaceutically acceptable salt thereof, to a method for preparing same, and to a pharmaceutical composition containing same as active ingredients for the diagnosis or treatment of neurodegenerative brain diseases. The aryl derivatives of the present invention are (3-fluoro-2-hydroxy)propyl-functionalized to increase the polarity thereof, and therefore the drugs containing the aryl derivatives can easily permeate into the cerebrovascular membrane, thus increasing the effectiveness of the drugs. As the aryl derivatives of the present invention strongly bind to β-amyloid, the aryl derivatives, when labeled with radioisotope, can be used as a diagnostic agent for non-invasively diagnosing early Alzheimer's disease. Further, the aryl derivatives of the present invention bind to low molecular β-amyloid peptide conjugates to inhibit the generation of malignant high molecular β-amyloid plaque, and thus can be effectively used as a therapeutic agent for neurodegenerative brain diseases such as Alzheimer's disease.

  本发明涉及（3-氟-2-羟基）丙基官能化芳基衍生物或其药用可接受的盐，以及制备该衍生物的方法，以及含有该衍生物作为活性成分的药物组合物，用于诊断或治疗神经退行性脑疾病。本发明的芳基衍生物经（3-氟-2-羟基）丙基官能化以增加其极性，因此含有该芳基衍生物的药物可以轻松渗透到脑血管膜中，从而增加药物的有效性。由于本发明的芳基衍生物与β-淀粉样蛋白结合强，因此当该芳基衍生物标记放射性同位素时，可用作无创诊断早期阿尔茨海默病的诊断剂。此外，本发明的芳基衍生物与低分子量β-淀粉样肽结合以抑制恶性高分子量β-淀粉样斑块的生成，因此可以有效用作治疗阿尔茨海默病等神经退行性脑疾病的治疗剂。
• [EN] TRICYCLIC MACROLIDE ANTIBACTERIAL COMPOUNDS<br/>[FR] COMPOSES ANTIBACTERIENS DE MACROLIDES TRICYCLIQUES
  申请人：ABBOTT LAB

  公开号：WO2003093289A1

  公开（公告）日：2003-11-13

  Antibacterial compounds having formula (I) and formula (II), and salts, prodrugs, and salts of prodrugs thereof, processes for making the compounds and intermediates used in the processes, compositions containing the compounds, and methods for prophylaxis or treatment of bacterial infections using the compounds are disclosed.

  具有化学式(I)和化学式(II)的抗菌化合物，以及这些化合物的盐、前药、前药的盐，制备这些化合物的方法以及用于制备过程中使用的中间体，含有这些化合物的组合物，以及使用这些化合物进行预防或治疗细菌感染的方法。
• Quinoline and naphthyridine carboxylic acid antibacterials
  申请人：——

  公开号：US20020049223A1

  公开（公告）日：2002-04-25

  Compounds having formula (I) 1 or pharmaceutically acceptable salts or prodrugs thereof, are useful as antibacterial agents.

  具有化学式(I)1的化合物或其药用可接受的盐或前药，可用作抗菌剂。